Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.

Clinical immunology (Orlando, Fla.) - 1 Aug 2009

Buraczynska Monika, Ksiazek Piotr, Zukowski Pawel, Benedyk-Lorens Ewa, Orlowska-Kowalik Grazyna

Abstract excerpt

The main cause of increased mortality in end-stage renal disease (ESRD) is cardiovascular disease (CVD). Complement factor H (CFH) may affect risk of CVD. Our study investigates a role of CFH Y402H polymorphism as a potential risk factor of CVD in a large group of patients. A group of 1200 patients with ESRD and 818 healthy controls were genotyped for the Y402H (T1277C) polymorphism. There was a significant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Kidney Failure, Chronic

Share to Linkage Disequilibrium

Share to Logistic Models

Share to Multivariate Analysis

Share to Risk Factors

Source

Identifiers

PMID: 19428307
DOI: 10.1016/j.clim.2009.04.005

Genes

CFH

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.PMID 19428307Read ↗

Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.Semantic proximity Read ↗

Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.Semantic proximity Read ↗

Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women.Semantic proximity Read ↗

Associations of CFH polymorphisms and CFHR1-CFHR3 deletion with blood pressure and hypertension in Chinese population.Semantic proximity Read ↗

A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.Semantic proximity Read ↗

Polymorphism related to cardiovascular risk in hemodialysis subjects: a systematic review.Semantic proximity Read ↗

Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.Semantic proximity Read ↗

Complement factor H Y402H gene polymorphism and coronary heart disease susceptibility: a meta-analysis.Semantic proximity Read ↗

Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study.Semantic proximity Read ↗

Correlation of hemochromatosis gene mutations and cardiovascular disease in hemodialysis patients.Semantic proximity Read ↗

Gene polymorphism association studies in dialysis: cardiovascular disease.Semantic proximity Read ↗

Relation between development of cardiovascular disease and the C242T CYBA polymorphism of the NADPH oxidase in ESRD patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.